Severe tricuspid regurgitation is predictive for adverse events in tetralogy of Fallot

被引:40
|
作者
Bokma, Jouke P. [1 ,2 ]
Winter, Michiel M. [1 ]
Oosterhof, Thomas [1 ]
Vliegen, Hubert W. [3 ]
van Dijk, Arie P. [4 ]
Hazekamp, Mark G. [5 ,6 ]
Koolbergen, Dave R. [5 ,6 ]
Groenink, Maarten [1 ]
Mulder, Barbara J. M. [1 ,2 ]
Bouma, Berto J. [1 ,2 ]
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Cardiol, NL-1105 AZ Amsterdam, Netherlands
[2] Interuniv Cardiol Inst, Utrecht, Netherlands
[3] Leiden Univ, Med Ctr, Dept Cardiol, Leiden, Netherlands
[4] Radboud Univ Nijmegen, Med Ctr Nijmegen, Dept Cardiol, NL-6525 ED Nijmegen, Netherlands
[5] Univ Amsterdam, Acad Med Ctr, Dept Cardiothorac Surg, NL-1105 AZ Amsterdam, Netherlands
[6] Leiden Univ, Med Ctr, Dept Cardiothorac Surg, Leiden, Netherlands
关键词
PULMONARY VALVE-REPLACEMENT; CONGENITAL HEART-DISEASE; CARDIOVASCULAR MAGNETIC-RESONANCE; RIGHT-VENTRICULAR FUNCTION; CORRECTED TETRALOGY; REPAIRED TETRALOGY; FOLLOW-UP; CLINICAL-OUTCOMES; QRS DURATION; RISK-FACTORS;
D O I
10.1136/heartjnl-2014-306919
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective Patients with surgically repaired tetralogy of Fallot (rTOF) may develop functional tricuspid regurgitation (TR) due to annulus dilation. Guidelines suggest pulmonary valve replacement (PVR) in patients with rTOF with progressive TR, but data on clinical outcomes are lacking. Our objective was to determine whether TR was predictive for adverse events after PVR. Methods In this retrospective, multicenter cohort study, patients with rTOF who had undergone PVR after preoperative echocardiographic assessment of TR grade were included. Preoperative and postoperative imaging data and a composite of adverse clinical events (death, sustained ventricular tachycardia, heart failure, or supraventricular tachycardia) were collected. Multivariate Cox hazards regression analysis was used to determine which factors were predictive for adverse events after PVR. Results A total of 129 patients (61% men, age at PVR 32.9 +/- 10.4 years) were included. The composite endpoint occurred in 39 patients during 8.4 +/- 4.2 years of follow-up. In multivariate analysis, severe preoperative TR (HR 2.49, 95% CI 1.11 to 5.52), right ventricular end-systolic volume (HR 1.02/mL/m(2), 95% CI 1.01 to 1.03) and age at PVR (HR 1.07/year, 95% CI 1.04 to 1.09) were predictive for adverse events. Early postoperative TR was not predictive for adverse events (p= 0.96). In patients without any risk factor (age > 40 years, right ventricular end-systolic volume > 90 mL/m(2) or severe TR), 5-year event-free survival was 100% as compared with 61% in patients with two or three risk factors. Conclusions In patients with rTOF, severe preoperative TR was predictive for adverse events after PVR. Close surveillance is warranted in these patients irrespective of postoperative TR.
引用
收藏
页码:794 / 799
页数:6
相关论文
共 50 条
  • [1] Tricuspid Regurgitation in Patients with Tetralogy of Fallot
    DeZorzi, Christopher
    Marenco, Anais
    Valente, Anne Marie
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (07)
  • [2] Clinical course of tricuspid regurgitation in repaired tetralogy of Fallot
    Woudstra, O. I.
    Bokma, J. P.
    Winter, M. M.
    Kies, P.
    Jongbloed, M. R. M.
    Vliegen, H. W.
    Groenink, M.
    Meijboom, F. J.
    Mulder, B. J. M.
    Bouma, B. J.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 243 : 191 - 193
  • [3] Prevalence and determinants of tricuspid regurgitation after repair of tetralogy of Fallot
    Offen, Sophie
    Puranik, Raj
    Baker, David
    Cordina, Rachael
    Chard, Richard
    Celermajer, David S.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2023, 372 : 55 - 59
  • [4] Severe pulmonary regurgitation in adolescents with tetralogy of Fallot leads to increased longitudinal strain
    Ylitalo, Pekka
    Lehmonen, Lauri
    Lauerma, Kirsi
    Holmstrom, Miia
    Pitkanen-Argillander, Olli
    Jokinen, Eero
    MAGNETIC RESONANCE MATERIALS IN PHYSICS BIOLOGY AND MEDICINE, 2020, 33 (02) : 309 - 316
  • [5] Adverse remodelling in tetralogy of Fallot: From risk factors to imaging analysis and future perspectives
    Avesani, Martina
    Jalal, Zakaria
    Friedberg, Mark K.
    Villemain, Olivier
    Venet, Maeyls
    Di Salvo, Giovanni
    Thambo, Jean-Benoit
    Iriart, Xavier
    HELLENIC JOURNAL OF CARDIOLOGY, 2024, 75 : 48 - 59
  • [6] Pulmonary regurgitation after repaired tetralogy of Fallot: surgical versus percutaneous treatment
    Meca Aguirrezabalaga, Juan Antonio
    Silva Guisasola, Jacobo
    Diaz Mendez, Rocio
    Escalera Veizaga, Alain Eliott
    Hernandez-Vaquero Panizo, Daniel
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (15)
  • [7] Echocardiographic parameters of severe pulmonary regurgitation after surgical repair of tetralogy of Fallot
    Van Berendoncks, An
    Van Grootel, Roderick
    McGhie, Jackie
    van Kranenburg, Matthijs
    Menting, Myrthe
    Cuypers, Judith A. A. E.
    Bogers, Ad J. J. C.
    Witsenburg, Maarten
    Roos-Hesselink, Jolien W.
    van den Bosch, Annemien E.
    CONGENITAL HEART DISEASE, 2019, 14 (04) : 628 - 637
  • [8] Implications of atrial volumes in surgical corrected Tetralogy of Fallot on clinical adverse events
    Ali, Lamia Ait
    Lurz, Philipp
    Ripoli, Andrea
    Rossi, Giuseppe
    Kister, Tobias
    Aquaro, Giovanni Donato
    Passino, C.
    Bonhoeffer, Philipp
    Festa, Pierluigi
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2019, 283 : 107 - 111
  • [9] NT-proBNP Indicates Left Ventricular Impairment and Adverse Clinical Outcome in Patients With Tetralogy of Fallot and Pulmonary Regurgitation
    Westhoff-Bleck, Mechthild
    Kornau, Finn
    Haghikia, Arash
    Horke, Alexander
    Bertram, Harald
    Treptau, Jens
    Widder, Julian
    Bauersachs, Johann
    Brehm, Michael-Ulrich
    CANADIAN JOURNAL OF CARDIOLOGY, 2016, 32 (10) : 1247.e29 - 1247.e36
  • [10] Right ventricular contractile reserve in tetralogy of Fallot patients with pulmonary regurgitation
    Kingsley, Clotilde
    Ahmad, Saad
    Pappachan, John
    Khambekar, Sujata
    Smith, Thomas
    Gardiner, Diane
    Shambrook, James
    Baskar, Shankar
    Moore, Ryan
    Veldtman, Gruschen
    CONGENITAL HEART DISEASE, 2018, 13 (02) : 288 - 294